Findings

What do systematic reviews say?

3 questions · 6 findings · 1 reviews · Skin

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 50%Moderate 3 · 50%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Related · question page
- Complete cure and adverse events for terbinafine vs griseofulvin · Proportion of participants with complete cure
  Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
  RR 1.06 [0.98, 1.15]
  3 studies · 328 participants
  Low
Related · question page
- Complete cure and adverse events for terbinafine vs griseofulvin · Adverse events attributed to the study drugs
  Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
  RR 1.11 [0.79, 1.57]
  1 study · 1549 participants
  Moderate
Related · question page
- Complete cure and adverse events for terbinafine vs griseofulvin · Severe adverse events
  Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
  RR 0.97 [0.24, 3.88]
  1 study · 1549 participants
  Moderate

Complete cure and adverse events for terbinafine vs griseofulvin

Proportion of participants with complete cure · children with tinea capitis

Complete cure and adverse events for terbinafine showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty).

4 findings from 1 review

Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 1.06 [0.98, 1.15]
3 studies · 328 participants
Low
Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 1.18 [0.74, 1.88]
1 study · 1006 participants
Low
Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 0.68 [0.53, 0.86]
2 studies · 334 participants
Moderate

Show 1 more finding

Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 0.45 [0.15, 1.35]
1 study · 21 participants
Low

Complete cure and adverse events for terbinafine vs griseofulvin

Adverse events attributed to the study drugs · children with tinea capitis

Complete cure and adverse events for terbinafine showed no clear difference in adverse events attributed to the study drugs compared with griseofulvin (moderate certainty).

1 finding from 1 review

Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 1.11 [0.79, 1.57]
1 study · 1549 participants
Moderate

Complete cure and adverse events for terbinafine vs griseofulvin

Severe adverse events · children with tinea capitis

Complete cure and adverse events for terbinafine showed no clear difference in severe adverse events compared with griseofulvin (moderate certainty).

1 finding from 1 review

Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 0.97 [0.24, 3.88]
1 study · 1549 participants
Moderate